Drug Reps' OT Case To Take Center Stage At High Court

Law360, New York (April 13, 2012, 8:01 PM EDT) -- The U.S. Supreme Court will hear oral arguments Monday on whether GlaxoSmithKline PLC's sales representatives are entitled to overtime pay, in a case that could not only be a huge financial blow to the drug industry, but also alter how much weight courts must give to regulators' opinions across the board.

The outcome of the case will most directly affect pharmaceutical companies, which have long classified drug representatives — who are legally prohibited from closing sales — as overtime-exempt salespeople under the Fair Labor Standards Act....
To view the full article, register now.